Policy ForumPoint-Counterpoint

Patient Autonomy and Incidental Findings in Clinical Genomics

See allHide authors and affiliations

Science  31 May 2013:
Vol. 340, Issue 6136, pp. 1049-1050
DOI: 10.1126/science.1239119

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Exome and whole-genome sequencing are rapidly moving into clinical application to aid diagnosis and treatment. However, a startling statement by the American College of Medical Genetics and Genomics (ACMG) may prove to be a stumbling block (1). Rather than reconfirming well-established principles of patient autonomy and informed consent that have long applied in medical genetics and in medical practice more broadly, ACMG recommends an abrupt change.